X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Thumbnail
Vaccine maker AstraZeneca said its £28bn acquisition of rare diseases company Alexion Pharmaceuticals was completed yesterday. [Read More]
Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock has soared amid the pandemic after... [Read More]
Save As
Preview
Preview